Scope Although sarcopenia is mainly caused by aging, sarcopenia due to obesity has
become an emerging issue given the increase in obesity among people of various ages …

This study was to investigate the protective role of luteolin on inflammation-mediated
metabolic diseases, focusing on the role of luteolin in the modulation of the Toll-like receptor …

Scope Mast cells play important roles in diet‐induced obesity and diabetes, and some
synthetic mast cell stabilizers can improve related metabolic disturbances in mice. Luteolin …

The flavonoid luteolin has various pharmacological activities. However, few studies exist on
the in vivo mechanism underlying the actions of luteolin in hepatic steatosis and obesity. The …

Obesity is a multi‐factorial metabolic syndrome that increases the risk of cardiovascular
diseases, diabetes, and cancer. We recently demonstrated the antiadipogenic efficacy of …

Aims/hypothesis Inflammatory polarisation of adipose tissue macrophages (ATMs) plays a
critical role in the development of obesity-associated metabolic diseases such as insulin …

Previously, we showed that loss of ovarian function in mice fed high-fat diet exacerbated
insulin resistance and adipose tissue inflammation. In the current study, we tested whether …

Purpose: Luteolin exerts beneficial effects against obesity-associated comorbidities,
although its influence on vascular dysfunction remains undetermined. We examined the …

Obesity and insulin resistance have been linked to a low-grade chronic inflammatory
response characterized by increased macrophage infiltration, altered cytokine production …

Obesity is characterized by excessive body fat accumulation and is a high-risk factor for
metabolic comorbidities, including type 2 diabetes, nonalcoholic fatty liver disease, and …